MTOR and neoplasm: Previously, we showed that feeding Apc+/Min mice the mTOR (mechanistic target of rapamycin) inhibitor rapamycin reduced their tumor burden to extend their lifespan by >5 times at their median survival (Hasty et al., 2014).